englischThe thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.

This thesis provides an overview on the technology and patenting practice, followed by the [...]

englischThe development of new medications and improvements thereof are crucial to ensure continued gains in health. The development process is long and costly, and mainly to produce the information to meet high regulatory requirements. In contrast, imitation involves negligible costs and much [...]

englischThe socio-economic and political characteristics of the Eastern and Southern Africa (ESA) jurisdictions call for a different approach to competition policy. Competition Policy in the ESA context draws one’s mind to three major themes: development, small market economies and regional [...]

englischIn patent communities several patentees cooperate contractually to licence the respective patented technologies to third parties. In consideration of the rising relevance of this business practice, this book discusses crucial courses and strategic considerations, which are the basis for the [...]

Die Neuerscheinung beschäftigt sich mit der Patentierbarkeit von nanotechnologischen Erfindungen.

englischThis book looks into the nature and status of Community collective marks and explores to what extent they can incorporate certification marks under the current European trade mark law. Welcoming the proposal for a new European Trade Mark Regulation in 2013, the study argues that the two [...]

englischThis book investigates lifecycle management strategies used by pharmaceutical companies attempting to maximize the value of their product portfolio. Such strategies are sometimes referred to by generic drug companies as “evergreening”. The analysis focuses on two of these strategies, namely [...]

englischTraditional medicines have and will continue to form the basis of modern pharmaceuticals. Many indigenous communities are claiming rights in pharmaceuticals derived from their traditional medicine. In the past, such knowledge derived from non-western communities was largely regarded as free [...]

englischThe EU data economy could double within the next years if policy and legal framework conditions are put in place in time. The first step has been taken by the EU with adoption of the GDPR, which introduced the right to data portability (RtDP). While the RtDP’s primary objective is to provide [...]

englischBetween 2013-2017, around 115 EU trademark applications were rejected on morality and public order grounds. In the GCC (six Arab and Islamic countries), anecdotal evidence suggests some refusals have bemused foreign applicants and highlighted cultural blindspots. In this context, this work [...]